Oncology

The annual masterclass, organised by the Saudi Oncology Society (SOS), addressed the knowledge gaps in breast cancer care in Saudi Arabia…

EMJ Oncology shares an impressive collection of new and interesting research, alongside our independent review of European Society for Medical Oncology (ESMO) Virtual Congress 2020 with research and breaking news from the virtual event.

Patients with BRAF V600E mutant metastatic colorectal cancer (mCRC) derive little benefit from standard therapies and have an extremely poor prognosis…

Cyclin-dependent kinase (CDK) 4/6 inhibitors in combination with endocrine therapy (ET) are considered the standard-of-care treatment for patients…

Up to 80% of patients with cancer are affected by chemotherapy-induced nausea and vomiting (CINV) if the appropriate preventive healthcare…

This Ferring-organised Meet-The-Expert symposium at the European Society of Medical Oncology (ESMO) 2019 meeting aimed to discuss new treatment…

This edition of EMJ Oncology 7.1 offers to the readers a wide range of topics and papers in relation to cancer diagnosis and management…

This review covers the inherent difficulties in stratifying early-stage breast cancer patients with regard to risk of recurrence.